Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis C L Correia

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Cardiology|March 24, 2012
Hyperglycemia and risk of acute coronary syndrome: myth or fact?Luis C L Correia
The New England Journal of Medicine|October 5, 2018
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or NutsLuis C L Correia
Arquivos Brasileiros De Cardiologia|March 31, 2016
Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT StudyLuis C L Correia
Current Vascular Pharmacology|July 14, 2007
Is there a true beneficial effect of statin therapy in the acute phase of unstable angina or myocardial infarction?Luis C L Correia
The New England Journal of Medicine|July 15, 2011
Stents versus CABG for left main coronary artery diseaseLuis C L Correia
The Lancet. Microbe|May 24, 2021
COVID-19 vaccines: effectiveness and number needed to treatLuis C L Correia, Denise Matias
Arquivos Brasileiros De Cardiologia|July 13, 2017
The Concept of Clinical Economics and its Relation with EffectivenessFranz Porzsolt, Luis C L Correia
Journal of the American College of Cardiology|August 27, 2011
Is reclassification of intermediate-risk subjects by coronary artery calcium scoring clinically useful?Luis C L Correia, Anis Rassi
Journal of the American College of Cardiology|April 21, 2012
The D-dimer approach for troponin in the diagnosis of myocardial infarction: is it really useful?Luis C L Correia, Márcia Noya-Rabelo
Circulation|July 12, 2021
Letter by Correia and Viana Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons"Luis C L Correia, Mateus S Viana
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Cardiology|March 24, 2012
Hyperglycemia and risk of acute coronary syndrome: myth or fact?Luis C L Correia
The New England Journal of Medicine|October 5, 2018
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or NutsLuis C L Correia
Arquivos Brasileiros De Cardiologia|March 31, 2016
Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT StudyLuis C L Correia
Current Vascular Pharmacology|July 14, 2007
Is there a true beneficial effect of statin therapy in the acute phase of unstable angina or myocardial infarction?Luis C L Correia
The New England Journal of Medicine|July 15, 2011
Stents versus CABG for left main coronary artery diseaseLuis C L Correia
The Lancet. Microbe|May 24, 2021
COVID-19 vaccines: effectiveness and number needed to treatLuis C L Correia, Denise Matias
Arquivos Brasileiros De Cardiologia|July 13, 2017
The Concept of Clinical Economics and its Relation with EffectivenessFranz Porzsolt, Luis C L Correia
Journal of the American College of Cardiology|August 27, 2011
Is reclassification of intermediate-risk subjects by coronary artery calcium scoring clinically useful?Luis C L Correia, Anis Rassi
Journal of the American College of Cardiology|April 21, 2012
The D-dimer approach for troponin in the diagnosis of myocardial infarction: is it really useful?Luis C L Correia, Márcia Noya-Rabelo
Circulation|July 12, 2021
Letter by Correia and Viana Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons"Luis C L Correia, Mateus S Viana
Pageof 6